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Abstract
Background: Assessment of risk for serious cardiovascular outcome after syncope is difficult.
Objectives: To determine the incidence of first syncope in primary care. To investigate the relation between
syncope and serious cardiovascular (CV) outcome and serious injury.
Methods: Retrospective cohort study using data from the Intego general practice-based registration network,
collecting data from 55 general practices (90 GP’s). All patients with a first syncope from 1994 to 2008 were
included; five participants without syncope were matched for age and gender for every patient with syncope. The
main outcome measures were incidence of first syncope by age and gender and one year risk of serious CV
outcome or injury after syncope.
Results: 2785 patients with syncope and 13909 matched patients without syncope were included. The overall
incidence of a first syncope was 1.91 per 1000 person-years (95% CI 1.83-1.98). The incidence was higher in females
(2.42 (95% CI 2.32-2.55) per 1000 person-years) compared to males (1.4 (95% CI 1.32-1.49) per 1000 person-years)
and follows a biphasic pattern according to age: a first peak at the age of 15-24 years is followed by a sharp rise
above the age of 45. One year serious outcome after syncope was recorded in 12.3% of patients. Increasing age
(HR 1.04 (1.03-1.04)), CV comorbidity (HR 3.48 (95% CI 2.48-4.90) and CV risk factors (HR 1.65 (95% CI 1.24-2.18) are
associated with serious outcome. Cox regression, adjusting for age, gender, CV comorbidity and risk factors,
showed that syncope was an independent risk factor for serious CV outcome or injury (HR 3.99 (95% CI 3.44-4.63)).
The other independent risk factors were CV comorbidity (HR 1.81 (95% CI 1.51-2.17)) and age (HR 1.03 (95% CI
1.03-1.04)).
Conclusions: Incidence rate of first syncope in primary care was 1.91 per 1000 person-years. One year risk of
serious outcome after syncope was 12.3%. Increasing age, CV comorbidity and risk factors are associated with
serious outcome. Compared to a control group, syncope on itself is an independent risk factor for serious outcome
(adjusted for age, gender, CV comorbidity and risk factors).
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Background
Syncope is a transient loss of consciousness due to glo-
bal cerebral hypo-perfusion characterized by rapid
onset, short duration and spontaneous complete recov-
e r y[ 1 ] .S u c ha ne v e n tm a yh a v em u l t i p l ep o s s i b l e
causes, from benign conditions to life-threatening dis-
ease [2]. Most studies on syncope were conducted in
emergency departments and general hospitals, but little
is known about incidences and outcome in a general
population or general practice.
Epidemiological data are scarce and reported as life-
time prevalence and incidence rates. In a general popu-
lation, lifetime prevalence in a Framingham cohort (3.0-
3.5%) was low compared to data from other populations
(19-39%) [3-7]. Incidence rates vary from 6.2 to 39.7 per
1000 person-years [8,9]. Recently, these general popula-
tion incidence rates were analyzed in relation to general
practice and emergency department data. Incidences
were respectively 9.3 and 0.7 visits per 1000 person-
years [9]. In other reports, the percentage of persons
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a doctor or visiting a hospital) was 37% and 56% [5,8].
Outcome after syncope is related to the cause of syn-
cope. Patients with syncope due to a cardiac cause have
higher mortality compared with patients with non-car-
diac causes [8]. However, Kapoor showed that syncope
in itself is not a risk factor for mortality, but underlying
heart disease is [10]. Serious short-term outcome
(including death, myocardial infarction, arrhythmia and
major therapeutic procedures) after Emergency Depart-
ment (ED) visit for syncope ranged from 6.1 to
11.5% [11,12]. Long term-outcome (one or two year
m o r t a l i t yo rs e v e r eo u t c o m e )r a n g e df r o m8 . 5t o
11.5% [12-14].
Several risk stratification tools to detect patients with
syncope at high risk for serious outcome have been
developed. Only two clinical decision rules are suffi-
ciently developed for use in practice (level 2 evidence
for clinical decision rules): San Francisco Syncope Rule
(SFSR) and The Osservatorio Epidemiologico sulla Sin-
cope nel Lazio(OESIL) risk score [15]. However, these
two rules showed considerable inconsistency across stu-
dies. Recently, the National Institute for Health and
Clinical Excellence (NICE) developed, after careful con-
sideration of the evidence, a guideline about the assess-
ment, diagnosis and specialist referral of adults and
young people who experienced a transient loss of con-
sciousness [16]. ‘Red flags’ were determined to identify
high risk patients for serious adverse events that should
have specialist assessment urgently.
The aim of the study is to determine the incidence of
first syncope as presented to GPs and to investigate
whether syncope is associated with increased cardiovas-
cular (CV) outcomes and serious injury within a general
practice population.
Methods
In this retrospective cohort study, we examined data
from general practices in Belgium providing data to the
Intego general practice registration network, from Janu-
ary 1th, 1994 to December 31th, 2008.
Data source
The Intego general practice registration network is coor-
dinated by the department of general practice of the
Katholieke Universiteit Leuven. This database contains
anonymised coded diagnoses (both detaiIed and Interna-
tional Classification of Primary Care codes (ICPC-
2)) [17], laboratory results and drug prescriptions. Sev-
eral studies are already published based on this data-
base [18-20]. Its validity was proven in a recent article
[21]. A total of 55 practices (90 GPs) located throughout
Flanders collaborate in this data collection process. GPs
present themselves for inclusion in the registry, but
before their data are accepted, their registration perfor-
mance is audited using a number of algorithms that
compares their results with all other applicants. Only
the data of the practices with the best performance
(from less than 50% of the applicants) are included in
the database. Incidence rates calculation requires know-
ing the size of the population (denominator). Since peo-
ple are only partially registered with a particular GP in
Belgium and may consult several different doctors, the
practice population is unknown. However, the yearly
contact group (the group of patients that consulted their
GP at least once a year) can easily be obtained from the
I n t e g od a t a b a s e .M o r e o v e r ,ar e l i a b l ee s t i m a t eo ft h e
Intego practice population (corresponding to 1.72% of
the population of Flanders) can be obtained by extrapo-
lating the yearly contact group by a correction factor
based on social security data [22].
Participants
’Exposed’ participants: We included all patients with a
first syncope, fainting, blackout, vasovagal reaction or
collapse (A06 ICPC-2 code) during the period January
1994 to December 2008. Date of diagnosis (A06 ICPC-2
code) was used as the baseline date.
’Unexposed’ participants: For each exposed patient 5
(randomly selected) additional patients without syncope
were matched with respect to age and gender. They
received a baseline date which was similar to the day of
diagnosis of the related exposed patient.
Variables
The (serious) outcome was defined as the occurrence of
a new CV event or serious injury within one year. New
CV events were myocardial inf a r c t i o n ,a r r h y t h m i a ,p u l -
monary embolism, stroke, subarachnoid haemor-
rhage [11]. Serious injury was defined as fractures and
intracranial hemorrhage.
In both groups CV comorbidity prior to the event
(myocardial infarction, angina, stroke or TIA and con-
gestive heart failure) and known CV risk factors (hyper-
tension, diabetes mellitus and hypercholesterolemia)
were recorded.
Statistical analysis
We calculated incidences (and 95% confidence intervals
(CI)) as the number of first syncope-registrations per
1000 patient-years in the practice population.
Survival analyses were performed to take account of
the censored nature of the data, whereby the date of
diagnosis of the exposed participants is used as the date
of origin. For the unexposed participants, the diagnosis
date of the matching exposed participant was used. For
censored observations (no serious outcome within one
year) only the last year of contact could be obtained,
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date of contact was set to 31 December of that year.
Kaplan- Meier curves were calculated for serious out-
come for patients with and without syncope. Logrank
test was used for comparison of survival curves.
In addition, we used Cox regression analysis to exam-
ine differences in outcome, adjusted for age, gender, CV
comorbidity and risk factors, and taking possible inter-
actions into consideration.
All analyses have been performed using MedCalc for
windows version, 11.3.0. (MedCalc Software, Maria-
kerke, Belgium) and SPSS for windows version 18.0
(SPSS, Chicago, IL, USA).
Results
Demographics
On average 185 patients with first syncope were
recorded yearly over the period 1994-2008. This signifies
2785 patients with syncope and 13909 control patients.
Follow up was incomplete (less than one year follow-up
without reaching the outcome measure) in 394 of the
syncope patients (14.7%) and 4352 of the control
patients (31.2%).
Incidence
The overall incidence of a first syncope was 1.91 per 1000
person-years (95% CI 1.83-1.98). The incidence in
females was higher (2.42 (95% CI 2.32-2.55) per 1000
person-years), as compared to males (1.4 (95% CI 1.32-
1.49) per 1000 person years). The annual incidence rates
over the study period vary from 0.80 (95% CI 0.57-1.09)
to 2.91 (95% CI 2.4-3.5) per 1000 person-years (Figure 1).
The incidence rates according to age follow a biphasic
pattern: a first peak at the age of 15 to 24 year is followed
by a sharp rise above the age of 45 (Figure 2).
Outcome after syncope
As shown in the Kaplan-Meier curve, 12,3% of the
patients with syncope have a serious outcome within
one year (Figure 3). There was no difference in outcome
when comparing male patients with female patients (HR
0.82 (95% CI 0.65-1.02). Patients having CV comorbidity
and CV risk factors have a significant higher risk of ser-
ious outcome compared to patients without these CV
risk factors (HR respectively 3.48 (95% CI 2.48-4.90) and
1.65 (95% CI 1.24-2.18)). Age is associated with serious
outcome: a one-year increase in age is associated with
4% increase in hazard rate (HR 1.04 (1.03-1.04)). An age
above 70 years or the presence of CV comorbidity
increases the likelihood of serious outcome (positive
likelihood ratio 2.22 (95% CI 2.05-2.41)).
Comparing patients with and without syncope
Table 1 shows the characteristics of syncope and control
patients. Syncope patients were more likely to have CV
comorbidity (12.3% vs. 5.7%, P < 0.0001) and risk factors
(18.7% vs. 11.3%, P < 0.0001). Mean age and gender
were comparable in both groups.
The Kaplan-Meier curve comparing syncope patients
with control patients shows that syncope is a risk factor
for serious outcome (HR 4.15 (95% CI 3.41-5.04)), with
exception for the younger age group (< 23 years old)
(HR 1.75 (95% CI 0.68 to 4.54), p = 0,17).
Cox regression, adjusting for age, gender, comorbidity
and CV risk factors, showed that syncope on itself was a
risk factor for serious outcome (HR 3.99 (95% CI 3.44-
Figure 1 Annual incidence of first syncope, from 1994 to 2008.
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comorbidity (HR 1.81 (95% CI 1.51-2.17)) and age (HR
1.03 (95% CI 1.03-1.04)). Interaction terms comorbidi-
ty*syncope, age*syncope and age*comorbidity were non
significant.
Figure 4 shows the one year serious outcome in syn-
cope and control patients according to CV comorbidity
and CV risk factors in different age groups.
Discussion
Incidences
Our study results show an incidence of first syncope vis-
its of 1.91 (95% CI 1.83-1.98) per 1000 person-years,
increasing with age and with a clear gender difference
(females 2.42 vs. males 1.40 per 1000 person-years). We
choose deliberately to investigate only first syncope
since patients with recurrent syncope are known to be
at decreased risk for serious outcome [23]. Our overall
incidence of syncope was 2.21 per 1000 person-years
(95% CI 2.14-2.29).
Dutch general practice based data from LINH (Nether-
lands Information Network of General Practice) and the
Amsterdam Transition Project show similar age and gen-
der differences, but higher overall incidences (respec-
tively 3.8 and 9.3 per 1000 person-years) [24,25]. A large
population based study (mean age 51 (range 20-96)
found an incidence of first syncope of 6.2 per 1000 per-
son-years, age dependent with a sharp rise at 70 years,
but with similar rates among men and women [8]. Keep-
ing in mind that only 37% [5] to 56% [8] of patients with
syncope seek medical attention (seeing a doctor or visit-
ing a hospital) after syncope, our rates are comparable.
Outcome after syncope
In our study, serious outcome within one year after syn-
cope occurs in 12.3% of the patients.
In a general population-based study, outcome after
syncope was dependent on the cause of syncope. One
and 5 year mortality after cardiac syncope (including
ischemia or arrhythmias) was approximately 15 and 45%
respectively [8]. Previous prognostic studies of syncope
in the ED show one year mortality ranging from 6% to
15.4% [12-14,26]. The STePS study, reporting on short
and long term prognosis of syncope patients presenting
in the ED, showed one year overall mortality of 6% and
serious outcomes other than death (comprising cardio-
pulmonary resuscitation, pacemaker or ICD implanta-
tion, intensive care unit admittance and acute
Figure 2 Incidence of first syncope according to age group.
Figure 3 Kaplan-Meier curve showing one year serious
outcome after first syncope.
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lected in the ED syncope population cannot simply be
extrapolated to general practice as was shown by Olde
Nordkamp [9]. Using ED data in comparison to general
practice data the author showed that the event rate for
syncope in general practice (9.3/1000 patient-years)
exceeded the presentation rate in the ED/chest pain unit
by a factor 13.3 [9].
Predictors for serious outcome
Predictors for serious outcome after syncope in our
study are increasing age, CV comorbidity and CV risk
factors. Our predictors of serious outcome after syncope
are in keeping with literature data, originating from the
ED. Abnormal ECG, history of ventricular arrhythmia,
history of cardiovascular disease (including ischemic
heart disease and congestive heart failure and TIA or
stroke) were found to be independent predictors for ser-
ious outcome (including death and arrhythmias) for
patients presenting with syncope in the ED [12,26,27].
Older age is associated with poor outcome, but the
upper limit of low risk varies, from an age group > 45
years to the age of > 65 years (more often) [12,26,27].
Moreover, both coexistence of neoplasm and non-white
race were found to be predictors for serious out-
come [12,26]. Compared to a control group, syncope is
a risk factor for serious outcome in our study, except in
the younger age group (< 23 years old). This can result
from insufficient power as both the incidence of syncope
and the incidence of additional risk factors are lower in
this age group. It can, however, also indicate a real
absence of such an association. Although we are not
aware of the causes of syncope in our patient popula-
tion, reflex syncope is much more frequent than all
other causes of syncope in the young and no increased
mortality has been found in subjects that had suffered
reflex syncope [28].
Limitations
The Intego database does not provide mortality data nor
information on signs, symptoms or additional test
results e.g. ECG. Therefore, we were not able to test
such information as either a measure of outcome or a
possible risk factor.
The organization of primary care in Belgium is char-
acterized by private system of health care delivery, based
on independent medical practice, free choice of service
provider and predominantly fee-for-service payment [29].
As several different categories of primary care organiza-
tions exist in and outside Europe [30], our data cannot
be simply extrapolated to other countries.
Implications
Although incidences of syncope in primary care are
low, serious outcome after syncope is frequent. The
Table 1 Characteristics of index and control patients
Syncope
N = 2785
Control
N = 13909
Mean age 54.5 54.5 NS
Male gender (%) 37.2 37.2 NS
CV comorbidity (%) 12.3 5.70 p < 0.0001
CV risk factors (%) 18.7 11.3 P < 0.0001
CV = cardiovascular
Figure 4 One year serious outcome in first syncope and control patients according to CV comorbidity and risk factors. ‘CV pos’:C V
comorbidity OR risk factors prior to the baseline date.
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syncope, based on all available evidence, seems to
concentrate on age, CV risk factors and comorbidity.
It is important that these risk factors seem largely
similar over different settings (general population,
general practice and ED). However current risk strati-
fying tools, developed in the ED, lack accuracy to
determine patients at high risk for serious outcome.
Further research should attempt to address the fol-
lowing question. How to detect patients with syncope
that need immediate referral and additional testing.
Does referral or hospitalization affect short- or long-
term outcome?
Conclusions
I n c i d e n c er a t eo ff i r s ts y n c o p ei np r i m a r yc a r ew a s1 . 9 1
per 1000 person-years. One year risk of serious outcome
after syncope was 12.3%. Increasing age, CV comorbidity
and risk factors are associated with serious outcome.
Compared to a control group, syncope on itself is an
independent risk factor for serious outcome (adjusted
for age, gender, CV comorbidity and risk factors).
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